Physician profile
Mousa Hamad
NPI 1518499540
$3,280.32
in general payments reported to CMS, 2019-2025
8 companies · $2,578 in 2025
The $2,578 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $229 · 2024: $473 · 2025: $2,578.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,759 · Food and Beverage: $1,155 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,758.53 |
| Food and Beverage | $1,155.38 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,539.25 | 2024-2025 | Teligen, Vistaseal |
| Depuy Synthes Sales INC. | $667.94 | 2024-2025 | Trialtis, Teligen, Expedium |
| Globus Medical, INC. | $596.31 | 2025 | Excelsius Gps |
| Nico Corporation | $229.40 | 2021 | |
| Arteriocyte Medical Systems, INC. | $111.84 | 2025 | Magellan |
| Icotec Medical INC. | $69.14 | 2025 | Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm, Vader Pedicle System 6.0, Screw, Carbon/Peek, Polyax., Fen., O 5.5 X 45 Mm, Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm |
| Integra Lifesciences Corporation | $41.52 | 2024 | Cusa Clarity, Duraseal Exact Spinal Sealant System, Codman Certas |
| Medtronic, INC. | $24.92 | 2025 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mousa Hamad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.